Related Experiment Video
Updated: May 7, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
New Perspectives in Neuroprotection for Ischemic Stroke
María Pérez-Mato1, Esteban López-Arias1, Ana Bugallo-Casal1
1Translational Stroke Laboratory Group (TREAT), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
Abstract:
The constant failure of new neuroprotective therapies for ischemic stroke has partially halted the search for new therapies in recent years, mainly because of the high investment risk required to develop a new treatment for a complex pathology, such as stroke, with a narrow intervention window and associated comorbidities. However, owing to recent progress in understanding the stroke pathophysiology, improvement in patient care in stroke units, development of new imaging techniques, search for new biomarkers for early diagnosis, and increasingly widespread use of mechanical recanalization therapies, new opportunities have opened for the study of neuroprotection. This review summarizes the main protective agents currently in use, some of which are already in the clinical evaluation phase. It also includes an analysis of how recanalization therapies, new imaging techniques, and biomarkers have improved their efficacy.
Insights
Despite past failures, new advances in understanding ischemic stroke and improved treatments like mechanical recanalization offer renewed hope for developing effective neuroprotective therapies.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Background:
- Previous neuroprotective therapies for ischemic stroke have largely failed, increasing development risks.
- Stroke is a complex condition with a narrow treatment window and comorbidities, hindering therapeutic progress.
Purpose of the Study:
- To review current neuroprotective agents for ischemic stroke.
- To analyze how recent advancements enhance neuroprotection efficacy.
Main Methods:
- Literature review of neuroprotective agents.
- Analysis of recanalization therapies, imaging, and biomarkers' impact on stroke treatment.
Main Results:
- Several neuroprotective agents are in clinical evaluation.
- Recanalization therapies, advanced imaging, and biomarkers show promise in improving stroke outcomes.
Conclusions:
- Recent progress in stroke pathophysiology and treatment strategies creates new opportunities for neuroprotection research.
- Combination of therapies and advanced diagnostics may improve the efficacy of neuroprotective treatments for ischemic stroke.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology

